{
    "eid": "2-s2.0-85165557992",
    "title": "Molecular Farming Strategy for the Rapid Production of Protein-Based Reagents for Use in Infectious Disease Diagnostics",
    "cover-date": "2022-12-09",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Complementary and Alternative Medicine",
            "@code": "2707",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "Biopharmaceuticals",
        "diagnostics",
        "molecular farming",
        "plant biotechnology",
        "recombinant proteins",
        "transient expression"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Perawat Jirarojwattana",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 1,
    "ref-count": 71,
    "ref-list": [
        "Zoonotic disease programs for enhancing global health security",
        "Six decades of lateral flow immunoassay: From determining metabolic markers to diagnosing COVID-19",
        "Point of care diagnostics in resource-limited settings: A review of the present and future of PoC in its most needed environment",
        "Escherichia coli as an antibody expression host for the production of diagnostic proteins: significance and expression",
        "Expression of mammalian proteins for diagnostics and therapeutics: A review",
        "Recent advances in mammalian protein production",
        "Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements",
        "Recent developments in bioprocessing of recombinant proteins: expression hosts and process development",
        "Production of Recombinant Proteins",
        "A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants",
        "The production of recombinant pharmaceutical proteins in plants",
        "Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond",
        "Recombinant Protein Production in Plants: A Brief Overview of Strengths and Challenges",
        "Regulation of molecular farming products",
        "Plant molecular farming for the production of valuable proteins - Critical evaluation of achievements and future challenges",
        "Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19",
        "Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and \u2265 50 years old adults",
        "Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine",
        "Addressing demand for recombinant biopharmaceuticals in the COVID-19 era",
        "Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins",
        "Biotechnological insights on the expression and production of antimicrobial peptides in plants",
        "Plant-based vaccines against viruses",
        "Plant factories for the production of monoclonal antibodies",
        "Potential of plant biologics to tackle the epidemic like situations - case studies involving viral and bacterial candidates",
        "Harnessing the potential of plant expression system towards the production of vaccines for the prevention of human papillomavirus and cervical cancer",
        "Plant platforms for efficient heterologous protein production",
        "Compendium on food crop plants as a platform for pharmaceutical protein production",
        "Contributions of the international plant science community to the fight against human infectious diseases - part 1: Epidemic and pandemic diseases",
        "Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases",
        "Plant molecular pharming for the treatment of chronic and infectious diseases",
        "Plant molecular farming: Much more than medicines",
        "Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants",
        "Advances in plant molecular farming",
        "Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies",
        "Plant-based vaccines against COVID-19 for massive vaccination in Africa",
        "COVID-19 crisis: How can plant biotechnology help?",
        "Plant molecular farming: A viable platform for recombinant biopharmaceutical production",
        "The emergency response capacity of plant-based biopharmaceutical manufacturing-what it is and what it could be",
        "Molecular farming - The slope of enlightenment",
        "Recent developments in therapeutic protein expression technologies in plants",
        "Current status and perspectives of the molecular farming landscape",
        "Development of systems for the for the production of plant-derived biopharmaceuticals",
        "Antigen production in plant to tackle infectious diseases flare up: The case of SARS",
        "Detection of serum antibodies to hepatitis E virus based on HEV genotype 3 ORF2 capsid protein expressed in Nicotiana benthamiana",
        "Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen",
        "Transient expression of dengue virus NS1 antigen in Nicotiana benthamiana for use as a diagnostic antigen",
        "The C-terminal half of SARS-CoV-2 nucleocapsid protein, industrially produced in plants, is valid as antigen in COVID-19 serological tests",
        "Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis",
        "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",
        "Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States",
        "Bovine leukaemia virus: Current epidemiological circumstance and future prospective",
        "Transient expression of a bovine leukemia virus envelope glycoprotein in plants by a recombinant TBSV vector",
        "Expression of porcine reproductive and respiratory syndrome virus nucleocapsid protein in nicotiana benthamiana for diagnostic applications",
        "Development of a novel assay based on plant-produced infectious bursal disease virus VP3 for the differentiation of infected from vaccinated animals",
        "Emergence of novel coronavirus 2019-nCoV: Need for rapid vaccine and biologics development",
        "Plant expression systems as an economical alternative for the production of iELISA coating antigen AHSV VP7",
        "Development and optimization of an enzyme immunoassay to detect serum antibodies against the hepatitis e virus in pigs, using plant-derived ORF2 recombinant protein",
        "SARS-CoV-2 antigens expressed in plants detect antibody responses in COVID-19 patients",
        "Usefulness of ELISA using total antibody against plant-expressed recombinant nucleocapsid protein of SARS-CoV-2",
        "Development of diagnostic tools for IBDV detection using plants as bioreactors",
        "Efficient plant production of recombinant NS1 protein for diagnosis of dengue",
        "A plant-produced recombinant fusion protein-based newcastle disease subunit vaccine and rapid differential diagnosis platform",
        "Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus",
        "Validation of an ELISA for the concurrent detection of total antibodies (IgM and IgG) to Rift Valley fever virus",
        "Plant-produced Crimean-Congo haemorrhagic fever virus nucleoprotein for use in indirect ELISA",
        "Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection",
        "Antigen production using heterologous expression of dengue virus-2 non-structural protein 1 (NS1) in Nicotiana tabacum (Havana) for immunodiagnostic purposes",
        "Immunodiagnostic properties of Wucheraria bancrofti SXP-1, a potential filarial diagnostic candidate expressed in tobacco plant, Nicotiana tabacum",
        "Dengue virus tetra-epitope peptide expressed in lettuce chloroplasts for potential use in dengue diagnosis",
        "Preserved antigenicity of HIV-1 p24 produced and purified in high yields from plants inoculated with a tobacco mosaic virus (TMV)-derived vector"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "128203322",
            "affilname": "Baiya Phytopharm Co. Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128203322",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}